ADVANCED CERVICAL CANCER
Clinical trials for ADVANCED CERVICAL CANCER explained in plain language.
Never miss a new study
Get alerted when new ADVANCED CERVICAL CANCER trials appear
Sign up with your email to follow new studies for ADVANCED CERVICAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo shows promise for tough gynecological cancers
Disease control Recruiting nowThis study tests an experimental drug called SKB518, given alone or with chemotherapy, in 280 people with advanced ovarian, cervical, or endometrial cancers. The goal is to see if the drug can shrink tumors or slow cancer growth. Researchers will also monitor side effects.
Matched conditions: ADVANCED CERVICAL CANCER
Phase: PHASE2 • Sponsor: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Immunotherapy drug could boost cervical cancer treatment
Disease control Recruiting nowThis phase 3 trial tests whether adding the immunotherapy drug adebrelimab to standard chemoradiotherapy helps people with locally advanced cervical cancer live longer without their cancer getting worse. About 720 participants will receive either adebrelimab or a placebo alongsid…
Matched conditions: ADVANCED CERVICAL CANCER
Phase: PHASE3 • Sponsor: Shanghai Shengdi Pharmaceutical Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Immune cell combo shows promise against tough gynecologic cancers
Disease control Recruiting nowThis early-phase study tests a new treatment that combines specially grown immune cells (cCTL) with immunotherapy for people with advanced gynecologic cancers like ovarian, cervical, or endometrial cancer. The goal is to see if the combination is safe and can shrink tumors. About…
Matched conditions: ADVANCED CERVICAL CANCER
Phase: EARLY_PHASE1 • Sponsor: Obstetrics & Gynecology Hospital of Fudan University • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
New drug duo targets hard-to-treat cancers in early trial
Disease control Recruiting nowThis study tests a combination of two experimental drugs, ZGGS18 and ZG005, in people with advanced solid tumors (cervical, liver, neuroendocrine, or lung cancer) that no longer respond to standard treatments. The main goals are to check safety, find the best dose, and see if the…
Matched conditions: ADVANCED CERVICAL CANCER
Phase: PHASE1, PHASE2 • Sponsor: Suzhou Zelgen Biopharmaceuticals Co.,Ltd • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC